AQP9 and hepatocellular carcinoma: Moreover, when overexpressing AQP9 in HCC cells, the levels of Wnt/β-catenin signaling and EMT-associated molecules were diminished while cell apoptosis was increased, suggesting the possible relevance of AQP9 as both a drug target and diagnostic molecule in HCC [31,33].